IDEAS home Printed from https://ideas.repec.org/a/eee/eurman/v14y1996i6p638-647.html
   My bibliography  Save this article

Separating research from development: Evidence from the pharmaceutical industry

Author

Listed:
  • Chiesa, Vittorio

Abstract

From an organisational point of view, corporate research and development (R&D) has always been viewed as one function. That view, however, has undergone some changes in the last few years, and many major corporations have changed their R&D organisation or re-thought their overall structure on the basis of their technical competencies. With the example of the pharmaceutical industry, in which R&D has a particularly strong role to play, Vittorio Chiesa reports on a survey of nine major pharmaceutical firms which have recently instigated such changes. Among the changes are a separation of the 'research' and 'development' activities organisationally and sometimes physically. The author puts forward explanations for this trend and weighs the advantages and disadvantages.

Suggested Citation

  • Chiesa, Vittorio, 1996. "Separating research from development: Evidence from the pharmaceutical industry," European Management Journal, Elsevier, vol. 14(6), pages 638-647, December.
    • Handle: RePEc:eee:eurman:v:14:y:1996:i:6:p:638-647
    as

    Download full text from publisher

    File URL: http://www.sciencedirect.com/science/article/pii/S0263237396000606
    Download Restriction: Full text for ScienceDirect subscribers only
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Criscuolo, Paola, 2005. "On the road again: Researcher mobility inside the R&D network," Research Policy, Elsevier, vol. 34(9), pages 1350-1365, November.
    2. Santiago-Rodriguez, Fernando, 2010. "Human resource management and learning for innovation: pharmaceuticals in Mexico," MERIT Working Papers 2010-002, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).
    3. Chris van Egeraat and Frank Barry, 2008. "The Irish Pharmaceutical Industry over the Boom Period and Beyond," The Institute for International Integration Studies Discussion Paper Series iiisdp271, IIIS.
    4. André Spithoven, Belgian Science Policy Office and Ghent University & Michel Dumont & Peter Teirlinck, Belgian Science Policy Office and KU Leuven, 2014. "Working Paper 08-14 - Public support for R&D and the educational mix of R&D employees," Working Papers 1408, Federal Planning Bureau, Belgium.
    5. Santiago-Rodriguez, Fernando & Dutrenit, Gabriela, 2010. "Determinants of PRO-industry interactions in pharmaceutical R&D: the case of Mexico," MERIT Working Papers 2010-053, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).
    6. Dominique Perrochon & Didier Lebert, 2000. "L'utilisation des notions de confiance et de proximité dans l'étude des processus de R&D pharmaceutiques," Cahiers de la Maison des Sciences Economiques r00056, Université Panthéon-Sorbonne (Paris 1).
    7. Becker, Markus C. & Lillemark, Morten, 2006. "Marketing/R&D integration in the pharmaceutical industry," Research Policy, Elsevier, vol. 35(1), pages 105-120, February.
    8. Paola Criscuolo & Rajneesh Narula, 2007. "Using multi-hub structures for international R&D: Organisational inertia and the challenges of implementation," Management International Review, Springer, vol. 47(5), pages 639-660, September.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:eurman:v:14:y:1996:i:6:p:638-647. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu (email available below). General contact details of provider: http://www.elsevier.com/wps/find/journaldescription.cws_home/115/description#description .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.